000 01171 a2200337 4500
005 20250517130922.0
264 0 _c20161219
008 201612s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc1609483
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGordon, Craig E
245 0 0 _aAcetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus.
_h[electronic resource]
260 _bThe New England journal of medicine
_c11 2016
300 _a2008-2009 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAcetazolamide
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aDiabetes Insipidus, Nephrogenic
_xchemically induced
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aLithium Compounds
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsychotropic Drugs
_xadverse effects
650 0 4 _aUrine
700 1 _aVantzelfde, Swapna
700 1 _aFrancis, Jean M
773 0 _tThe New England journal of medicine
_gvol. 375
_gno. 20
_gp. 2008-2009
856 4 0 _uhttps://doi.org/10.1056/NEJMc1609483
_zAvailable from publisher's website
999 _c26692670
_d26692670